{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:13:25Z","timestamp":1790230405619,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10147-017-1117-y","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:52:01Z","timestamp":1491439921000},"page":"793-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Patient perceptions of symptoms and concerns during cancer chemotherapy: \u2018affects my family\u2019 is the most important"],"prefix":"10.1007","volume":"22","author":[{"given":"H.","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"1117_CR1","first-page":"1113","volume":"19","author":"S Tominaga","year":"1992","unstructured":"Tominaga S (1992) Trends in cancer mortality, incidence and survival in Japan. Gan To Kagaku Ryoho 19:1113\u20131120","journal-title":"Gan To Kagaku Ryoho"},{"key":"1117_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","volume":"19","author":"A Coates","year":"1983","unstructured":"Coates A, Abraham S, Kaye SB (1983) On the receiving end\u2013patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203\u2013208","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1117_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.annonc.a010548","volume":"7","author":"AM Griffin","year":"1996","unstructured":"Griffin AM, Butow PN, Coates AS et al (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189\u2013195","journal-title":"Ann Oncol"},{"key":"1117_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","volume":"95","author":"N Carelle","year":"2002","unstructured":"Carelle N, Piotto E, Bellanger A (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95:155\u2013163","journal-title":"Cancer"},{"key":"1117_CR5","volume-title":"Guidelines for appropriate use of antiemetic drugs, version 1","author":"Japan Society of Clinical Oncology","year":"2010","unstructured":"Japan Society of Clinical Oncology (2010) Guidelines for appropriate use of antiemetic drugs, version 1. Kanehara, Tokyo"},{"key":"1117_CR6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T et al (2015) CINV Study Group of Japan testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20:855\u2013865","journal-title":"Int J Clin Oncol"},{"key":"1117_CR7","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","volume":"32","author":"JE Bower","year":"2014","unstructured":"Bower JE, Bak K, Berger A et al (2014) American Society of Clinical Oncology: screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 32:1840\u20131850","journal-title":"J Clin Oncol"},{"key":"1117_CR8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jnci\/djn250","volume":"100","author":"O Minton","year":"2008","unstructured":"Minton O, Richardson A, Sharpe M et al (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. Natl Cancer Inst 100:1155\u20131166","journal-title":"Natl Cancer Inst"},{"key":"1117_CR9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jjco\/hyu060","volume":"44","author":"M Yokoo","year":"2014","unstructured":"Yokoo M, Akechi T, Takayama T et al (2014) Comprehensive assessment of cancer patients\u2019 concerns and the association with quality of life. Jpn J Clin Oncol 44:670\u2013676","journal-title":"Jpn J Clin Oncol"},{"key":"1117_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2003.09.001","volume":"43","author":"J Dancey","year":"2004","unstructured":"Dancey J, Shepherd FA, Gralla RJ et al (2004) Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 43:183\u2013194","journal-title":"Lung Cancer"},{"key":"1117_CR11","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM198712103172402","volume":"317","author":"A Coates","year":"1987","unstructured":"Coates A, Gebski V, Bishop JF et al (1987) Improving the quality of life during chemotherapy for advanced breast cancer; A comparison of intermittent and continuous treatment strategies. N Engl J Med 317:1490\u20131495","journal-title":"N Engl J Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-017-1117-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-017-1117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T13:41:41Z","timestamp":1501249301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-017-1117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1007\/s10147-017-1117-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}